Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-17

Clinical Trial Update: Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal Period [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether maternal and neonatal probiotics prevent allergic diseases in infants; the study (NCT00325273) is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotics

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Atopic Dermatitis, Allergic Rhinitis | Phase 3 | Status: COMPLETED